Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Total Current Liabilities (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Total Current Liabilities was $15.65 billion in Q2 2026, up 31.9% from $11.86 billion a year earlier and up 15.6% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Total Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Teva Pharmaceutical Industries came in at $13.46 billion, up 5.2% from FY2024.

  • Total Current Liabilities has now increased for four consecutive years, with a five-year compound annual growth rate of 0.4% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $12.8 billion in FY2024 (+4.5%), $12.25 billion in FY2023 (+6.8%), $11.47 billion in FY2022 (+4.0%) and $11.03 billion in FY2021 (-16.2%).
  • The Q2 2026 figure marks the highest quarterly Total Current Liabilities since Q4 2017.
  • Compared with a year earlier, Total Current Liabilities has increased for three straight quarters, with growth averaging 4.9% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q1 2024 (growth of 32.5%); the worst was Q1 2025 (a decline of 19.1%).
  • Per Business Quant data, TEVA's Total Current Liabilities in the three quarters before Q2 2026 was $13.53 billion (Q1 2026), $13.46 billion (Q4 2025) and $11.49 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 15.65 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.65 Bn
Mar 31, 2026 13.53 Bn
Dec 31, 2025 13.46 Bn
Sep 30, 2025 11.49 Bn
Jun 30, 2025 11.86 Bn
Mar 31, 2025 11.16 Bn
Dec 31, 2024 12.80 Bn
Sep 30, 2024 13.80 Bn
Jun 30, 2024 13.04 Bn
Mar 31, 2024 13.79 Bn
Dec 31, 2023 12.25 Bn
Sep 30, 2023 11.39 Bn
Jun 30, 2023 11.84 Bn
Mar 31, 2023 10.41 Bn
Dec 31, 2022 11.47 Bn
Sep 30, 2022 11.53 Bn
Jun 30, 2022 11.00 Bn
Mar 31, 2022 11.61 Bn
Dec 31, 2021 11.03 Bn
Sep 30, 2021 11.83 Bn
API Access

Teva Pharmaceutical Industries Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TEVA&period=max&api_key=YOUR_API_KEY